The Institute of Chinese Medical Sciences (ICMS) of the University of Macau (UM) held the ‘1st Symposium on Computational Pharmaceutics—AI and Modeling in Pharma 4.0’ from 14 to 16 December 2024. The symposium brought together experts from world-renowned universities, including the Massachusetts Institute of Technology, the University of Copenhagen, and Peking University, to discuss the latest advancements and challenges in computational pharmaceutics.
In his opening remarks, UM Vice Rector Ge Wei highlighted the immense potential of artificial intelligence (AI) in the pharmaceutical sector, and UM’s commitment to promoting technological innovation and interdisciplinary collaboration.
The symposium featured speakers from prestigious institutions worldwide, including Uppsala University in Sweden, the University of Surrey in the UK, the University of Helsinki in Finland, the Massachusetts Institute of Technology and the University of the Pacific in the US, the University of Copenhagen in Denmark, the University of Toronto in Canada, Peking University, Shanghai Jiao Tong University, Central South University, Jinan University, Guangdong University of Technology, Macao Polytechnic University, and UM. They shared their research and practices in the field of computational pharmaceutics, and discussed in depth the applications of computational pharmaceutics in drug discovery and development, the applications of AI in drug delivery, and the applications of multi-scale modelling, high-performance computing, and robotics in drug research and development. Experts from the pharmaceutical industry also actively engaged in the discussions, furthering the development of computational pharmaceutics.
The symposium provided an important platform for academia, industry, and government sectors to facilitate communication and cooperation. The successful hosting of the event highlights Macao’s growing international influence at the intersection of AI and pharmaceuticals, and injects new vitality into Macao’s technological innovation and sustainable development. UM will continue to support and promote the development of AI in the pharmaceutical sector.
